- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04686019
More Air - Better Performance - Faster Recovery (IMT)
"More Air - Better Performance - Faster Recovery": Study Protocol for a Randomised Controlled Trial of the Effect of Inspiratory Muscle Training for Adults Post-stroke
The objective of this study is to investigate i) the effect of 3 weeks IMT to adults post-stroke to maximal inspiratory pressure (MIP) and ii) the effects of 3 weeks IMT to the degree of dependency in activities of daily living, endurance in gait, fatigue, voice volume, phonation endurance, and expiratory function.
Methods/Design: Randomised controlled trial (RCT) comparing IMT to conventional neurorehabilitation (usual practise). 80 patients, with reduced maximal inspiration pressure (MIP) hospitalized at a specialized neurorehabilitation hospital in Denmark will be included.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Stroke results in varying disabilities physical, cognitive, emotional and/or social both in short term and long term. Motor impairments are significantly persistent consequences post-stroke among these are decreased respiratory muscle function, decreased ability to expand thorax and postural dysfunction. These deficits influence the patient's ability in daily activities, fatigue, endurance and quality of life. Inspiratory muscle training (IMT) is training to improve the strength and endurance of diaphragm and the external intercostal muscles. The objective of this study is to investigate i) the effect of 3 weeks IMT to adults post-stroke to maximal inspiratory pressure (MIP) and ii) the effects of 3 weeks IMT to the degree of dependency in activities of daily living, endurance in gait, fatigue, voice volume, phonation endurance, and expiratory function.
Methods/Design: Randomised controlled trial (RCT) comparing IMT to conventional neurorehabilitation (usual practise). 80 patients, with reduced maximal inspiration pressure (MIP) hospitalized at a specialized neurorehabilitation hospital in Denmark will be included. The intervention group will add-on IMT sessions exercising at 30 % of MIP. Patients in the intervention group perform 2 sessions a day (One session of IMT with IMT threshold flute consists of 2 times 15 inspirations in normal breathing rhythm (5-10 min)), 7 days a week for 3 weeks. Training can be with or without supervision of physiotherapist.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Hanne Pallesen, Post Doc
- Phone Number: 004523821365
- Email: hannpall@rm.dk
Study Contact Backup
- Name: Simon S Kjeldsen, PhD student
- Email: simokjel@rm.dk
Study Locations
-
-
-
Hammel, Denmark, 8450
- Recruiting
- Regional Hospital Hammel Neurocenter
-
Contact:
- Hanne Pallesen, post doc
- Phone Number: +4523821365
- Email: hannpall@rm.dk
-
Contact:
- Simon S Kjeldsen, post doc
- Email: simokjel@rm.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- First time brain infarction or brain haemorrhage 0-6 month.
- Able to give written consent and being cognitive and communicative able to understand and participate in the maximal inspiration pressure test (MIP)
- Reduced MIP below gender and age specific normal standard
Exclusion Criteria:
- Diagnosis of myocardial infarction within the last 3 months
- Significant pulmonary disease (severe COPD), saturation below 90 if having COPD for others saturation below 92
- Neurological deficits other than stroke
- Facial palsy that affects proper labial occlusion
- Dizziness or nausea/vomiting during MIP-testing.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention group
|
IMT and conventional neurorehabilitation - treatment as usual. The intervention group will add-on IMT sessions exercising at 30 % of MIP. MIP is measured by instructing the patient to perform five forceful inspirations against an occluded mouthpiece (Power Breath). The best score is multiplied by 0.3 to determine the resistance. IMT is performed with IMT Threshold flute with the calculated resistance. During the measurement with Power Breath the patient sits straight up and uses nose clip. The patient can receive help to hold the Power Breath if necessary. One session of IMT with IMT threshold flute consists of 2 times 15 inspirations in normal breathing rhythm (5-10 min). Patients in the intervention group perform 2 sessions a day (morning and evening), training is performed prior to a meal, 7 days a week for 3 weeks. |
|
ACTIVE_COMPARATOR: Control group
Conventional neurorehabilitation
|
IMT and conventional neurorehabilitation - treatment as usual. The intervention group will add-on IMT sessions exercising at 30 % of MIP. MIP is measured by instructing the patient to perform five forceful inspirations against an occluded mouthpiece (Power Breath). The best score is multiplied by 0.3 to determine the resistance. IMT is performed with IMT Threshold flute with the calculated resistance. During the measurement with Power Breath the patient sits straight up and uses nose clip. The patient can receive help to hold the Power Breath if necessary. One session of IMT with IMT threshold flute consists of 2 times 15 inspirations in normal breathing rhythm (5-10 min). Patients in the intervention group perform 2 sessions a day (morning and evening), training is performed prior to a meal, 7 days a week for 3 weeks. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximal inspiratory pressure (MIP)
Time Frame: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention
|
Change of MIP assess with the Power Breath.
This is an objective measurement to describe the inspiratory capacity.
Age specific
|
Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Independence Measure (FIM) - both total score ( range from 18 to 126, with higher scores indicating more independence) and motor sub score (max 91)
Time Frame: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention
|
to assess the degree of changed dependency in daily activities
|
Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention
|
|
Fatigue Severity Scale (FSS)
Time Frame: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention
|
to measure change of fatigue (1-63) higher scores indicating more fatigue affected.
|
Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention
|
|
6-minutes walking test
Time Frame: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention
|
to measure change of endurance
|
Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention
|
|
Voice volume
Time Frame: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention
|
to measure change of voice volume by recording of an a-sound with the App Voice Analyst and to measure Phonation endurance (how long the a-sound last)
|
Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention
|
|
Expiratory function
Time Frame: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention
|
To measure change of Peak expiratory flow (PEF), Forced expiratory volume in 1 second (FEV1), Forced vital capacity (FVC) and FEV1/FVC ratio will be assessed with a peak flow meter (Spirometry device Micro 6300)
|
Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Jørgen F Nielsen, Professor, Hammel Neurorehabilitation and Research Centre, University of Aarhus, Hammel, Denmark
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-16-02-279-20
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Insufficiency
-
Hospital Israelita Albert EinsteinRecruitingRespiratory Insufficiency in ChildrenBrazil
-
Vyaire MedicalCompletedRespiratory Insufficiency in ChildrenUnited Kingdom, Poland, Netherlands
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingRespiratory Insufficiency Requiring Mechanical VentilationChina
-
Vyaire MedicalCompletedRespiratory Insufficiency in ChildrenNetherlands, Poland
-
Shanghai 10th People's HospitalUnknownPatients With Respiratory InsufficiencyChina
-
Erasme University HospitalCentre Hospitalier Régional de la CitadelleNot yet recruitingRespiratory Insufficiency Requiring Mechanical VentilationBelgium
-
Fondazione Salvatore MaugeriAzienda Ospedaliero, Universitaria Pisana; Ataturk Training and Research HospitalCompletedChronic Respiratory InsufficiencyItaly
-
ADIR AssociationSuspendedCOPD | Chronic Respiratory InsufficiencyFrance
-
Hamilton Medical AGRecruitingRespiratory Insufficiency Requiring Mechanical VentilationSwitzerland
-
GCS Ramsay Santé pour l'Enseignement et la RechercheNot yet recruiting
Clinical Trials on Inspiratory muscle training (IMT)
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)CompletedBlood Pressure | Exercise Capacity | Respiratory Muscle | Sympathetic Nerve ActivityUnited States
-
Fondazione Don Carlo Gnocchi OnlusAssociazione Italiana Glicogenosi (AIG); Associazione Riabilitatori Insufficienza... and other collaboratorsRecruitingGlycogen Storage Disease Type II | Pompe Disease (Late-onset)Italy
-
Istanbul UniversityNot yet recruiting
-
Johns Hopkins UniversityWithdrawnPulmonary Atelectasis | Pneumonia, Ventilator-AssociatedUnited States
-
University of CadizRecruitingMyocardial Ischemia | Coronary Arterial Disease (CAD)Spain
-
Universitas PadjadjaranDr. Hasan Sadikin General Hospital, Bandung, IndonesiaNot yet recruitingChronic Obstructive Pulmonary Disease (COPD) | Diaphragm Dysfunction
-
Izmir University of EconomicsNot yet recruitingNon-erosive Reflux Disease (NERD)Turkey (Türkiye)
-
Elif KabasakalRecruitingBronchiectasis | Functional Inspiratory Muscle TrainingTurkey (Türkiye)
-
Izmir University of EconomicsCompletedStress Urinary Incontinence (SUI)Turkey
-
Saglik Bilimleri UniversitesiCompletedChronic Obstructive Pulmonary Disease (COPD)Turkey (Türkiye)